Pemazyre – The FGFR2 Circuit Breaker By Steve|2025-06-09T11:46:42+10:00June 6th, 2025|Categories: All, Treatments & Trials|Tags: FGFR2 fusion, FGFR2 inhibitor, Fusion Mutation, iCCA, inhibitor, Pemazyre, Pemigatinib, targeted therapy| Read More 0
IDH1-Mutated Cholangiocarcinoma: Understanding PARP Inhibitors and Clinical Trials By Steve|2024-10-14T16:43:27+10:00September 25th, 2024|Categories: All, Q&A, Z-Legacy|Tags: ATR Inhibitors, clinical, Clinical Trial, iCCA, IDH1 Mutation, PARP Inhibitors, RAD-3, Shruti| Read More 0